top of page

Leczenie autyzmu - jak sobie poradzić 

Czy wiesz jaka jest skuteczna terapia dla dzieci z autyzmem ? Czy wiesz o tym jakie korzyści daje wpływ komory hiperbarycznej (1.3 Ata) dla dzieci ze spektrum autyzmu ? :

 

  • komórki mózgowe tzw."uśpione"zostają pobudzone i sprawne do działania

  • zwiększa się i pobudza produkcja serotoniny - hormon , który przekazuje informacje pomiędzy komórkami mózgowymi

  • zmniejszenie stanów zapalnych

  • zwiększa się rozpuszczalność tlenu w osoczu krwi

  • cały mózg dziecka zostaje dotleniony

  • całe ukrwienie poprawia się

  • podczas tlenoterapii tworzy się 10-krotnie więcej komórek macierzystych, a to sprawia że zastępowane są uszkodzone komórki

  • poprawia się jakość snu

​

Leczenie Autyzmu Radom

Autyzm u dzieci- jak pomóc

Dr. Dan Rossignol z Centrum Zasobów Rozwoju Dzieci na Florydzie niegdyś kwestionował skuteczność HBOT, jednak po zobaczeniu korzyści dla swoich dzieci dotkniętych ASD, zdecydował się zgłębić naukowe aspekty tlenoterapii hiperbarycznej. W 2009 roku przeprowadził badania kliniczne z 62 dziećmi z autyzmem, w wieku od 2 do 7 lat, które poddał 40 sesjom HBOT trwającym po godzinie. Badane dzieci zostały podzielone na dwie grupy.

 

  1. grupę oddychająca czystym tlenem pod ciśnieniem 1,3 ATA (30% wyższym od atmosferycznego).

  2. grupę wdychająca powietrze przy lekko podniesionym ciśnieniu 1,03 ATA (3% wyższym od atmosferycznego).

 

Przedstawiony fragment tekstu jest opisem wyników badań opublikowanych w piśmie „BMC Pediatrics”, dotyczących poprawy ogólnego funkcjonowania, rozumienia języka, kontaktów społecznych, kontaktu wzrokowego oraz świadomości czuciowej dzieci uczestniczących w dwóch grupach badawczych. Pierwsza grupa kontrolna, która poddała się sesjom HBOT, wykazała znacząco wyższy poziom poprawy (30%) w porównaniu z drugą grupą (8%). Ogółem zaobserwowano poprawę u 80% dzieci z grupy pierwszej i u 38% z grupy drugiej. Te wyniki są częścią opracowania w ramach naukowych badań naukowców i lekarzy jak leczyć autyzm u dzieci.

Leczenie Autyzmu Radom

zobrazowanie ukrwienia mózgu przed i po tlenoterapii

Spektrum autyzmu

Terapia HBOT (Tlenoterapia Hiperbaryczna) przynosi zauważalną poprawę u osób dotkniętych zaburzeniami ze spektrum autyzmu (ASD):

  1. Świadomość czuciowa

  2. Zwiększona zdolności percepcji

  3. Funkcjonowanie w kontaktach ze społeczeństwem

  4. Radzenie sobie z rozwiązywaniem problemów

  5. Większa aktywność i zaangażowanie

  6. Koncentracja na wykonywanych zadaniach

  7. Zrozumienie - dziecko staje się dociekliwe i obecne

U dzieci z autyzmem leczonych w komorze hiperbarycznej, analizy rezonansu magnetycznego mózgu wykazały poprawę perfuzji (przepływu krwi) w obszarach płata skroniowego u 82,4%, płata czołowego u 85,3%, oraz innych częściach mózgu u 78,2% pacjentów.

Leczenie Autyzmu Radom

zobrazowanie ukrwienia mózgu przed i po tlenoterapii

Terapia dla dzieci z autyzmem

Poniżej przedstawione zostały wyniki badań dr Rossignol’a, z 2012 r, które dotyczyły zmian w kolorowaniu przez 17-letnią nastolatkę ze spektrum autyzmu. Zauważamy że rysunek przedstawia kolorowankę dziewczynki przed rozpoczęciem terapii w komorze hiperbarycznej (rys. a), a następnie (rys. b) po tygodniowej terapii (5 sesji godzinnych, raz dziennie). W kolejnych tygodniach, (15 godzinnych sesji ) dziewczynka zaczyna dobierać odpowiednie kolory do pokolorowania Kubusia Puchatka i liści . Po 20 godzinach terapii zaczyna dobrze zachowywać granice pola do kolorowania. Tlenoterapia to jest znakomite wsparcie dla rodziców autystycznych dzieci.

Leczenie Autyzmu Radom

źródło: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472266/

Po 40 godzinach terapii tlenem hiperbarycznym o ciśnieniu 1,3 ATA zaobserwowano istotną poprawę interakcji społecznych, samokontroli oraz zdolności utrzymywania kontaktu wzrokowego u małych pacjentów. To ważne, że badano ciśnienie typowe nie tylko dla dużych komór, ale PRZEDE WSZYSTKIM dla jednoosobowych komór hiperbarycznych, w których dziecko może być z rodzicem.Dzięki stosowaniu HBOT dochodzi do znacznego zahamowania efektów ASD i nastąpuje widoczny rozwój w zakresie zdolności koncentracji, pamięci i mowy.

​

 

 

TEN FILM MÓWI WSZYSTKO - zadbajcie o to aby dziecko do Was wróciło...

Wsparcie dla rodziców autystycznych dzieci

Jeżeli jesteś zainteresowana lub zainteresowany aby skorzystać z Komory Hiperbarycznej, zapisz się już dzisiaj i skorzystaj z ceny promocyjnej:

1 sesja tlenoterapii za 119 zł zamiast 149 zł

5 sesji tlenoterapii za 499 zł zamiast 750 zł

10 sesji tlenoterapii za 800 zł zamiast 1500 zł

 

Zapisz się już dziś

Promocja ograniczona czasowo

Bibliografia na podstawie której został przygotowany artykuł :

 

1.Feldmeier JJ, Chairman and Editor: Hyperbaric oxygen 2003: indications and results: the hyperbaric oxygen therapy committee report. Kensington, MD: Undersea and Hyperbaric Medicine Society; 2003.

 

2. Leach RM, Rees PJ, Wilmshurst P: Hyperbaric oxygen therapy. BMJ 1998, 317(7166):1140–1143.

 

3. Shandling AH, Ellestad MH, Hart GB, Crump R, Marlow D, Van Natta B, Messenger JC, Strauss M, Stavitsky Y: Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. Am Heart J 1997, 134 (3):544–550.

 

4. Gill AL, Bell CN: Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004, 97(7):385–395.

 

5. Ackerman NB, Brinkley FB: Oxygen tensions in normal and ischemic tissues during hyperbaric therapy. Studies in rabbits. JAMA 1966, 198 (12):1280–1283.

 

6.Wang GH, Zhang XG, Jiang ZL, Li X, Peng LL, Li YC, Wang Y: Neuroprotective effects of hyperbaric oxygen treatment on traumatic brain injury in the rat. J Neurotrauma 2010, 27(9):1733–1743.

 

7. Palzur E, Zaaroor M, Vlodavsky E, Milman F, Soustiel JF: Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Res 2008, 1221:126–133.

 

8. Henninger N, Kuppers-Tiedt L, Sicard KM, Gunther A, Schneider D, Schwab S: Neuroprotective effect of hyperbaric oxygen therapy monitored by MRimaging after embolic stroke in rats. Exp Neurol 2006, 201(2):316–323.

 

9. Harch PG, Kriedt C, Van Meter KW, Sutherland RJ: Hyperbaric oxygen therapy improves spatial learning and memory in a rat model of chronic traumatic brain injury. Brain Res 2007, 1174:120–129.

 

10. Vlodavsky E, Palzur E, Soustiel JF: Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury. Neuropathol Appl Neurobiol 2006, 32(1):40–50.

 

11. Wright JK, Zant E, Groom K, Schlegel RE, Gilliland K: Case report: Treatment of mild traumatic brain injury with hyperbaric oxygen. Undersea Hyperb Med 2009, 36 (6):391–399.

 

12. Eovaldi B, Zanetti C: Hyperbaric oxygen ameliorates worsening signs and symptoms of post-traumatic stress disorder. Neuropsychiatr Dis Treat 2010, 6:785–789.

 

13. Lv LQ, Hou LJ, Yu MK, Ding XH, Qi XQ, Lu YC: Hyperbaric oxygen therapy in the management of paroxysmal sympathetic hyperactivity after severe traumatic brain injury: a report of 6 cases. Arch Phys Med Rehabil 2011, 92(9):1515–1518.

 

14. Stoller KP: Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/ CTE: two case reports. Med Gas Res 2011, 1(1):17.

 

15. Sahni T, Jain M, Prasad R, Sogani SK, Singh VP: Use of hyperbaric oxygen in traumatic brain injury: Retrospective analysis of data of 20 patients treated at a tertiary care centre. Br J Neurosurg 2011, 26(2):207.

 

16. Harch PG, Fogarty EF, Staab PK, Van Meter K: Low pressure hyperbaric oxygen therapy and SPECT brain imaging in the treatment of blastinduced chronic traumatic brain injury (post-concussion syndrome) and post traumatic stress disorder: a case report. Cases J 2009, 2:6538.

 

17. Harch P, Andrews SR, Fogarty E, Amen DG, Pezzullo JC, Lucarini J, Aubrey C, Taylor DV, Staab P, Van Meter K: A Phase I Study of Low Pressure Hyperbaric Oxygen Therapy for Blast-Induced Post Concussion Syndrome and Post Traumatic Stress Disorder. J Neurotrauma 2012, 29(1):168–185.

 

18. Rockswold SB, Rockswold GL, Zaun DA, Zhang X, Cerra CE, Bergman TA, Liu J: A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. J Neurosurg 2010, 112(5):1080–1094.

 

19. Shi XY, Tang ZQ, Xiong B, Bao JX, Sun D, Zhang YQ, Yao Y: Cerebral perfusion SPECT imaging for assessment of the effect of hyperbaric oxygen therapy on patients with postbrain injury neural status. Chin J Traumatol 2003, 6 (6):346–349.

 

20. Shi XY, Tang ZQ, Sun D, He XJ: Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury. Chin Med J (Engl) 2006, 119(23):1978–1982.

 

21. Hardy P, Johnston KM, De Beaumont L, Montgomery DL, Lecomte JM, Soucy JP, Bourbonnais D, Lassonde M: Pilot case study of the therapeutic potential of hyperbaric oxygen therapy on chronic brain injury. J Neurol Sci 2007, 253 (1–2):94–105.

 

22. Golden ZL, Neubauer R, Golden CJ, Greene L, Marsh J, Mleko A: Improvement in cerebral metabolism in chronic brain injury after hyperbaric oxygen therapy. Int J Neurosci 2002, 112(2):119–131.

 

23. Golden Z, Golden CJ, Neubauer RA: Improving neuropsychological function after chronic brain injury with hyperbaric oxygen. Disabil Rehabil 2006, 28 (22):1379–1386.

 

24. Helms A, Evans AW, Chu J, Sahgal A, Ostrowski R, Sosiak T, Wolf G, Gillett J, Whelan H: Hyperbaric oxygen for neurologic indications–action plan for multicenter trials in: stroke, traumatic brain injury, radiation encephalopathy & status migrainosus. Undersea Hyperb Med 2011, 38(5):309–319.

 

25. Stoller KP: Quantification of neurocognitive changes before, during, and after hyperbaric oxygen therapy in a case of fetal alcohol syndrome. Pediatrics 2005, 116(4):586–591.

 

26. Matchett GA, Martin RD, Zhang JH: Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms. Neurol Res 2009, 31 (2):114–121.

 

27. Huang L, Obenaus A: Hyperbaric oxygen therapy for traumatic brain injury. Med Gas Res 2011, 1(1):21.

 

28.Moss MC, Scholey AB: Oxygen administration enhances memory formation in healthy young adults. Psychopharmacology (Berl) 1996, 124 (3):255–260.

 

29. Scholey AB, Moss MC, Neave N, Wesnes K: Cognitive performance, hyperoxia, and heart rate following oxygen administration in healthy young adults. Physiol Behav 1999, 67(5):783–789.

 

30. Moss MC, Scholey AB, Wesnes K: Oxygen administration selectively enhances cognitive performance in healthy young adults: a placebocontrolled double-blind crossover study. Psychopharmacology (Berl) 1998, 138(1):27–33.

 

31. APA: Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.

 

32. Rice C: Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009, 58(10):1–20.

 

33. Schaefer GB, Mendelsohn NJ: Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med 2008, 10(1):4–12.

 

34. Rossignol DA, Frye RE: Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 2011, 17 (3):290–314.

 

35. Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL: Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010, 1:S1–18. 125 Suppl.

 

36. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, et al: Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006, 141(8):947–956.

 

37. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J: Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2010, 25(1):40–45.

 

38. Rossignol DA, Frye RE: A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 2011, 17(4):389–401.

 

39. Ming X, Brimacombe M, Chaaban J, Zimmerman-Bier B, Wagner GC: Autism spectrum disorders: concurrent clinical disorders. J Child Neurol 2008, 23 (1):6–13.

 

40. Herbert MR: Autism: a brain disorder or a disorder that affects the brain. Clinical Neuropsychiatry 2005, 2(6):354–379.

 

41. Lovaas OI: Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 1987, 55(1):3–9.

 

42. Sallows GO, Graupner TD: Intensive behavioral treatment for children with autism: four-year outcome and predictors. Am J Ment Retard 2005, 110(6):417–438.

 

43. Eikeseth S, Smith T, Jahr E, Eldevik S: Intensive behavioral treatment at school for 4- to 7-year-old children with autism. A 1-year comparison controlled study. Behav Modif 2002, 26(1):49–68.

 

44. Rossignol DA: Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Med Hypotheses 2007, 68 (6):1208–1227.

 

45. Buckley JA: How mild hyperbaric oxygen therapy works and why it is good for our children. Medical Veritas 2005, 2:647.

 

46. Stoller KP, Small T: Interview with Dr. Kenneth P. Stoller: Hyperbaric oxygen therapy (HBOT), Autism, Aspartame and Mercury. Medical, Veritas 2006, 3(1):957–966.

 

47. Harch PG, Small T: Interview with Dr Paul Harch: the application of hyperbaric oxygen therapy in chronic neurological conditions. Medical Veritas 2005, 2(2):637–646.

 

48. Rossignol DA, Small T: Interview with Dr. Dan A. Rossignol: hyperbaric oxygen therapy improves symptoms in autistic children. Medical Veritas 2006, 3:1–4.

 

49. Zilbovicius M, Boddaert N, Belin P, Poline JB, Remy P, Mangin JF, Thivard L, Barthelemy C, Samson Y: Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. Am J Psychiatry 2000, 157 (12):1988–1993.

 

50. Zilbovicius M, Garreau B, Tzourio N, Mazoyer B, Bruck B, Martinot JL, Raynaud C, Samson Y, Syrota A, Lelord G: Regional cerebral blood flow in childhood autism: a SPECT study. Am J Psychiatry 1992, 149(7):924–930.

 

51. Boddaert N, Zilbovicius M: Functional neuroimaging and childhood autism. Pediatr Radiol 2002, 32(1):1–7.

 

52. Starkstein SE, Vazquez S, Vrancic D, Nanclares V, Manes F, Piven J, Plebst C: SPECT findings in mentally retarded autistic individuals. J Neuropsychiatry Clin Neurosci 2000, 12(3):370–375.

 

53. Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, Sasaki M: Abnormal regional cerebral blood flow in childhood autism. Brain 2000, 123(Pt 9):1838–1844.

 

54. Critchley HD, Daly EM, Bullmore ET, Williams SC, Van Amelsvoort T, Robertson DM, Rowe A, Phillips M, McAlonan G, Howlin P, et al: The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000, 123(Pt 11):2203–2212.

 

55. Wilcox J, Tsuang MT, Ledger E, Algeo J, Schnurr T: Brain perfusion in autism varies with age. Neuropsychobiology 2002, 46(1):13–16.

 

56. Gendry Meresse I, Zilbovicius M, Boddaert N, Robel L, Philippe A, Sfaello I, Laurier L, Brunelle F, Samson Y, Mouren MC: Autism severity and temporal lobe functional abnormalities. Ann Neurol 2005, 58(3):466–469.

 

57. Heuser G, Heuser SA, Rodelander D, Aguilera O, Uszler M: In Treatment of neurologically impaired adults and children with “mild” hyperbaric oxygenation (1.3 atm and 24 % oxygen). In Hyperbaric oxygenation for cerebral palsy and the brain-injured child. Edited by Joiner JT. Flagstaff, Arizona: Best Publications; 2002.

 

58. Rossignol DA: The use of hyperbaric oxygen therapy in autism. In Hyperbaric oxygen for neurological disorders. Edited by Zhang JH. Flagstaff, AZ: Best Publishing Company; 2008:209–258.

 

59. The effects of hyperbaric oxygen therapy in children with autism spectrum disorders: [http://archive.rubicon-foundation.org/xmlui/handle/123456789/ 9163].

 

60. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ: Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 2003, 23(6):504–517.

 

61. Balzola F, Barbon V, Repici A, Rizzetto M, Clauser D, Gandione M, Sapino A: Panenteric IBD-like disease in a patient with regressive autism shown for the first time by the wireless capsule enteroscopy: another piece in the jigsaw of this gut-brain syndrome? Am J Gastroenterol 2005, 100(4):979–981.

 

62. Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, et al: Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001, 138(3):366–372.

 

63. Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, Wakefield AJ, Thomson MA, Walker-Smith JA: Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 2002, 7(4):375–382. 334.

 

64. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M: Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 2007, 36(6):361–365.

 

65. Ashwood P, Anthony A, Torrente F, Wakefield AJ: Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004, 24(6):664–673.

 

66. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M: Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207(1–2):111–116.

 

67. Jyonouchi H, Sun S, Le H: Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001, 120(1–2):170–179.

 

68. Messahel S, Pheasant AE, Pall H, Ahmed-Choudhury J, Sungum-Paliwal RS, Vostanis P: Urinary levels of neopterin and biopterin in autism. Neurosci Lett 1998, 241(1):17–20.

 

69. Sweeten TL, Posey DJ, McDougle CJ: High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 2003, 160(9):1691–1693.

 

70. Messahel S, Pheasant AE, Pall H, Kerr AM: Abnormalities in urinary pterin levels in Rett syndrome. Eur J Paediatr Neurol 2000, 4(5):211–217.

 

71. Akin ML, Gulluoglu BM, Uluutku H, Erenoglu C, Elbuken E, Yildirim S, Celenk T: Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med 2002, 29(4):279–285. Rossignol et al. Medical Gas Research 2012, 2:16 Page 11 of 13 http://www.medicalgasresearch.com/content/2/1/16

 

72. Luongo C, Imperatore F, Cuzzocrea S, Filippelli A, Scafuro MA, Mangoni G, Portolano F, Rossi F: Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 1998, 26(12):1972–1976.

 

73. Sumen G, Cimsit M, Eroglu L: Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats. Eur J Pharmacol 2001, 431(2):265–268.

 

74. Abbot NC, Beck JS, Carnochan FM, Gibbs JH, Harrison DK, James PB, Lowe JG: Effect of hyperoxia at 1 and 2 ATA on hypoxia and hypercapnia in human skin during experimental inflammation. J Appl Physiol 1994, 77 (2):767–773.

 

75. Takeshima F, Makiyama K, Doi T: Hyperbaric oxygen as adjunct therapy for Crohn's intractable enteric ulcer. Am J Gastroenterol 1999, 94(11):3374– 3375.

 

76. Nelson EW Jr, Bright DE, Villar LF: Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management. Dig Dis Sci 1990, 35(12):1561–1565.

 

77. Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S: Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 1994, 19(3): 202–205.

 

78. Granowitz EV, Skulsky EJ, Benson RM, Wright J, Garb JL, Cohen ER, Smithline EC, Brown RB: Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med 2002, 29(3):216–225.

 

79. Yang Z, Nandi J, Wang J, Bosco G, Gregory M, Chung C, Xie Y, Yang X, Camporesi EM: Hyperbaric oxygenation ameliorates indomethacininduced enteropathy in rats by modulating TNF-alpha and IL-1beta production. Dig Dis Sci 2006, 51(8):1426–1433.

 

80. Inamoto Y, Okuno F, Saito K, Tanaka Y, Watanabe K, Morimoto I, Yamashita U, Eto S: Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun 1991, 179(2):886–891.

 

81. Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, Pollack S: Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol 1997, 17(2):154–159.

 

82. Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR: Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 2006, 34(10):2624–2629.

 

83. Altinel O, Demirbas S, Cakir E, Yaman H, Ozerhan IH, Duran E, Cayci T, Akgul EO, Ersoz N, Uysal B, et al: Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest 2011, 71(3):185–192.

 

84. Rossignol DA: Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res 2012, 2(1):6.

85. Rossignol DA, Rossignol LW, James SJ, Melnyk S, Mumper E: The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatr 2007, 7(1):36.

 

86. Bent S, Bertoglio K, Ashwood P, Nemeth E, Hendren RL: Brief Report: Hyperbaric Oxygen Therapy (HBOT) in Children with Autism Spectrum Disorder: A Clinical Trial. J Autism Dev Disord 2011, .

 

87. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57(1):67–81.

 

88. Ashwood P, Van de Water J: A review of autism and the immune response. Clin Dev Immunol 2004, 11(2):165–174.

 

89. Frye RE, Rossignol DA: Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 2011, 69(5):41–47.

 

90. Dave KR, Prado R, Busto R, Raval AP, Bradley WG, Torbati D, Perez-Pinzon MA: Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience 2003, 120(1):113–120.

 

91. Boveris A, Chance B: The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973, 134 (3):707–716.

 

92. Daugherty WP, Levasseur JE, Sun D, Rockswold GL, Bullock MR: Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. J Neurosurg 2004, 101(3):499–504.

 

93. Gosalvez M, Castillo Olivares J, De Miguel E, Blanco M, Figuera D: Mitochondrial respiration and oxidative phosphorylation during hypothermic hyperbaric hepatic preservation. J Surg Res 1973, 15(5): 313–318.

 

94. Bar-Sagie D, Mayevsky A, Bartoov B: Effects of hyperbaric oxygenation on spermatozoan motility driven by mitochondrial respiration. J Appl Physiol 1981, 50(3):531–537.

 

95. Lou M, Chen Y, Ding M, Eschenfelder CC, Deuschl G: Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res Bull 2006, 69(2):109–116.

 

96. Calvert JW, Zhang JH: Oxygen treatment restores energy status following experimental neonatal hypoxia-ischemia. Pediatr Crit Care Med 2007, 8 (2):165–173.

 

97. Kurt B, Kurt Y, Karslioglu Y, Topal T, Erdamar H, Korkmaz A, Turkozkan N, Yaman H, Odabasi Z, Gunhan O: Effects of hyperbaric oxygen on energy production and xanthine oxidase levels in striated muscle tissue of healthy rats. J Clin Neurosci 2008, 15(4):445–450.

 

98. Gutsaeva DR, Suliman HB, Carraway MS, Demchenko IT, Piantadosi CA: Oxygen-induced mitochondrial biogenesis in the rat hippocampus. Neuroscience 2006, 137(2):493–504.

 

99. Van Dyke K: Hyperbaric oxygen therapy (HBOT) for autism: An introduction. Autism File 2009, 33:5–6.

 

100. Chauhan A, Chauhan V: Oxidative stress in autism. Pathophysiology 2006, 13(3):171–181.

 

101. Chauhan A, Chauhan V, Brown WT, Cohen I: Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin–the antioxidant proteins. Life Sci 2004, 75(21):2539–2549.

 

102. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA: Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004, 80 (6):1611–1617.

 

103. Alleva R, Nasole E, Di Donato F, Borghi B, Neuzil J, Tomasetti M: alphaLipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem Biophys Res Commun 2005, 333(2):404–410.

 

104. Ozden TA, Uzun H, Bohloli M, Toklu AS, Paksoy M, Simsek G, Durak H, Issever H, Ipek T: The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med 2004, 203(4):253–265.

 

105. Gregorevic P, Lynch GS, Williams DA: Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur J Appl Physiol 2001, 86(1):24–27.

 

106. Gulec B, Yasar M, Yildiz S, Oter S, Akay C, Deveci S, Sen D: Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res 2004, 53(5):493–499.

 

107. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z: Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab 2006, 26(5):666–674.

 

108. Sharifi M, Fares W, Abdel-Karim I, Koch JM, Sopko J, Adler D: Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. Am J Cardiol 2004, 93(12):1533–1535.

 

109. Speit G, Dennog C, Eichhorn U, Rothfuss A, Kaina B: Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Carcinogenesis 2000, 21 (10):1795–1799.

 

110. Rothfuss A, Radermacher P, Speit G: Involvement of heme oxygenase-1 (HO-1) in the adaptive protection of human lymphocytes after hyperbaric oxygen (HBO) treatment. Carcinogenesis 2001, 22(12):1979– 1985.

 

111. Rothfuss A, Speit G: Investigations on the mechanism of hyperbaric oxygen (HBO)-induced adaptive protection against oxidative stress. Mutat Res 2002, 508(1–2):157–165.

 

112. Thom SR: Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 2009, 106(3):988–995.

 

113. Audhya T: Autism Research Institute Garden Grove Think Tank Meeting, 2007. In Adjustment of SOD, GPO & catalase activity in RBC of normal and autistic children during hyperoxia. Garden Grove, CA:; 2007.

 

114. Dickinson DA, Forman HJ: Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 2002, 973:488–504.

 

115. Anonymous: Little Michael's development had stopped--It was called "childhood autism" until hyperbaric oxygen therapy!. Hyperbaric Oxygen Report 1994, 1(1):1–3.

 

116. Henricks CL: Ani’s story: A case study in late improvement in neurologic function after hyperbaric oxygenation therapy. J Amer Physicians Surg 2010, 15(3):94–95.

 

117. Burke C: Hyperbaric Oxygen Therapy. Supertwins Magazine 2007, 17(2):1–2.

 

118. Treating children with autism using hyperbaric oxygen therapy: [http://www. hyperbaricmedicinecenter.com/images/pdf/autism_study.pdf].

 

119. Rossignol DA, Rossignol LW: Hyperbaric oxygen therapy may improve symptoms in autistic children. Med Hypotheses 2006, 67(2):216–228.

 

120. Granpeesheh D, Tarbox J, Dixon DR, Wilke AE, Allen MS, Bradstreet JJ: Randomized trial of hyperbaric oxygen therapy for children with autism. Research Autism Spectrum Disorders 2010, 4:268–275.

 

121. Lerman DC, Sansbury T, Hovanetz A, Wolever E, Garcia A, O'Brien E, Adedipe H: Using behavior analysis to examine the outcomes of unproven therapies: An evaluation of hyperbaric oxygen therapy for children with autism. Behavior Analysis in Practice 2009, 1(2):50–58.

 

122. Chungpaibulpatana J, Sumpatanarax T, Thadakul N, Chantharatreerat C, Konkaew M, Aroonlimsawas M: Hyperbaric oxygen therapy in Thai autistic children. J Med Assoc Thai 2008, 91(8):1232–1238.

 

123. Jepson B, Granpeesheh D, Tarbox J, Olive ML, Stott C, Braud S, Yoo JH, Wakefield A, Allen MS: Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders. J Autism Dev Disord 2011, 41(5):575–588.

 

124. Ghanizadeh A: Hyperbaric oxygen therapy for treatment of children with autism, a systematic review of randomized trials. Med Gas Res 2012, 2 (1):13.

 

125. Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A, Neubrander J, Madren EM, Hintz G, Grushkin B, et al: Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr 2009, 9:21.

 

126. Cohen J: Statistical power analysis for the behavioral sciences (second edition). Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.

 

127. Clarke D: Effective patient blinding during hyperbaric trials. Undersea Hyperb Med 2009, 36(1):13–17.

 

128. Clarke RE, Tenorio LM, Hussey JR, Toklu AS, Cone DL, Hinojosa JG, Desai SP, Dominguez Parra L, Rodrigues SD, Long RJ, et al: Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys 2008, 72(1):134–143.

bottom of page